new_0222_0346|TPTX|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0346|TPTX|Long Name|1|1|Turning Point Therapeutics Inc Total Current Assets (Quarterly) (USD)|Turning Point Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Turning Point Therapeutics Inc Inventories (Quarterly) (USD)|Turning Point Therapeutics Inc Net PP&E (Quarterly) (USD)|Turning Point Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Turning Point Therapeutics Inc Total Liabilities (Quarterly) (USD)|Turning Point Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Turning Point Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Turning Point Therapeutics Inc Total Deposits (Quarterly) (USD)|Turning Point Therapeutics Inc Book Value (Quarterly) (USD)|Turning Point Therapeutics Inc Retained Earnings (Quarterly) (USD)|Turning Point Therapeutics Inc Treasury Stock (Quarterly) (USD)|Turning Point Therapeutics Inc EV to Revenues|Turning Point Therapeutics Inc EV to Earnings|Turning Point Therapeutics Inc EV to Free Cash Flow|Turning Point Therapeutics Inc EV to Assets (Quarterly)|Turning Point Therapeutics Inc PS Ratio|Turning Point Therapeutics Inc PE Ratio|Turning Point Therapeutics Inc Price to Book Value|Turning Point Therapeutics Inc PEG Ratio|Turning Point Therapeutics Inc Debt to Equity Ratio|Turning Point Therapeutics Inc Dividend Yield|Turning Point Therapeutics Inc Shareholder Yield (TTM)|Turning Point Therapeutics Inc Percent of Shares Outstanding Short|Turning Point Therapeutics Inc Total Receivables (Quarterly) (USD)|Turning Point Therapeutics Inc Total Payables (Quarterly) (USD)|Turning Point Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Turning Point Therapeutics Inc Return on Invested Capital|Turning Point Therapeutics Inc Quality Ratio Score|Turning Point Therapeutics Inc Momentum Score|Turning Point Therapeutics Inc Beta (1Y)|Turning Point Therapeutics Inc Sustainable Growth Rate (TTM)|Turning Point Therapeutics Inc Institutional Investor Ownership Percentage|Turning Point Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Turning Point Therapeutics Inc Total Employees (Annual)|Turning Point Therapeutics Inc EPS Diluted (Quarterly) (USD)|Turning Point Therapeutics Inc Shares Outstanding|Turning Point Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Turning Point Therapeutics Inc Ordinary Shares Number (Quarterly)|Turning Point Therapeutics Inc Payout Ratio|Turning Point Therapeutics Inc Quick Ratio (Quarterly)|Turning Point Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Turning Point Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Turning Point Therapeutics Inc Effective Tax Rate (TTM)|Turning Point Therapeutics Inc Return on Equity|Turning Point Therapeutics Inc Net Income (TTM) (USD)|Turning Point Therapeutics Inc Revenue (TTM) (USD)|Turning Point Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Turning Point Therapeutics Inc Revenue (Quarterly) (USD)|Turning Point Therapeutics Inc Gross Profit (Quarterly) (USD)|Turning Point Therapeutics Inc SG&A Expense (Quarterly) (USD)|Turning Point Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Turning Point Therapeutics Inc Net Income (Quarterly) (USD)|Turning Point Therapeutics Inc Net Interest Income (Quarterly) (USD)|Turning Point Therapeutics Inc Price (USD)|Turning Point Therapeutics Inc Total Return Price (USD)|Turning Point Therapeutics Inc Enterprise Value (USD)|Turning Point Therapeutics Inc 30-Day Average Daily Volume|Turning Point Therapeutics Inc 1 Year Price Returns (Daily)
new_0222_0346|TPTX|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0346|TPTX||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|daily|daily
new_0222_0346|TPTX||5|5|91.3333333333|91.3333333333|0|91.3333333333|0|91.3333333333|91.3333333333|91.3333333333|0|91.3333333333|91.3333333333|0|0|92|6.96732026144|91.4|0|0|6.97887323944|0|91.25|1.44836956522|92|15.2205882353|0|91.3333333333|91.3333333333|92|0|31.9|30.4090909091|92|0|91.4|92.6363636364|91.4|32.71875|0|91.3333333333|92|91.25|91.4|91.4285714286|0|92|91.3333333333|0|0|91.25|0|91.4|91.4|91.4|91.5|7.01315789474|7.01315789474|7.01315789474|6.95918367347|1.44628099174
new_0222_0346|TPTX||6|6|12|12|0|12|0|12|12|12|0|12|12|0|0|2|153|5|0|0|142|0|4|736|1|68|0|12|12|1|0|20|22|1|0|15|11|15|32|0|12|1|4|15|14|0|1|12|0|0|4|0|15|15|15|2|152|152|152|147|484
new_0222_0346|TPTX||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0346|TPTX|201803|201803|201803||||||||||||||||||||||||||||||||||14.938||-0.3168||||||-0.3168|||||||||0.516|-4.733|-4.733|0.127|||||
new_0222_0346|TPTX|201806|201806|201806||||||||||||||||||||||||||||||||||14.938||-0.3372||||||-0.3372|0||||||||0.803|-5.037|-5.037|0.135|||||
new_0222_0346|TPTX|201809|201809|201809||||||||||||||||||||||||||||||||||14.938||-0.4015||||||-0.4015|0||||||||1|-5.997|-5.997|0.132|||||
new_0222_0346|TPTX|201812|201812|201812|101.523|101.029||1||151.686|5.322|146.364||-48.406|-50.753|||||||||||||||1.494|0.001|||||||14.938||-0.6037|||27.7577|||-0.6037|0|||-24.785|||||2.259|-9.018|-9.018||||||
new_0222_0346|TPTX|201903|201903|201903|91.359|90.011||2.487||155.503|8.122|147.381||-60.005|-64.3|||||||||||||||2.697|0.001|||||||27.7577|63|-0.488|||27.7577|||-0.488|-0.022|||-33.599|||||3.614|-13.547|-13.547||||||
new_0222_0346|TPTX|201904|201903|201903|||||||||||||||-26.1772|||||||0||0.1116|||||||||||||29.6547||||||||||||||||||28.24|28.24|747.4377||
new_0222_0346|TPTX|201905|201903|201903|||||||||||||||-40.6324|||||||0||2.6931|||||||||||||31.2001||||||||||||||||||40.07|40.07|1160.177|302792.1333|
new_0222_0346|TPTX|201906|201906|201906|255.168|250.17||2.204||9.53|7.888|1.642||247.915|-81.442||||-39.5506|||||||0||3.7661||4.086|0.034|||||||24.4798|77|-0.7|31.2974||31.2974|||-0.7|-175.129|||-45.704|||||4.743|-17.142|-17.142||39.08|39.08|1129.2889|194807.1333|
new_0222_0346|TPTX|201907|201906|201906|||||||||||||||-24.6664||||5.032|||0||5.439|||||||||||||31.3364||||||||||||||||||39.84|39.84|998.2722|202696.7667|
new_0222_0346|TPTX|201908|201906|201906|||||||||||||||-38.3946||||6.8294|||0||7.2127|||||||||||||||||||||||||||||||57.57|57.57|1553.8665|112962.1333|
new_0222_0346|TPTX|201909|201909|201909|429.37|423.575||6.945||15.864|11.72|4.144||420.524|-101.925||||-28.9722||||5.8124|||0||6.3532||3.811|0.004|||||||32.3128|87|-0.63|35.8392||35.8392|||-0.63|-190.186|||-60.19|||||5.5|-20.483|-20.483||39.7|39.7|1172.5351|309190.4667|
new_0222_0346|TPTX|201910|201909|201909|||||||||||||||-17.9732||||3.2156|||0||6.2076|||||||||||||35.8495||||||||||||||||||38.19|38.19|945.5174|319973|
new_0222_0346|TPTX|201911|201909|201909|||||||||||||||-30.5189||||4.7953|||0||8.2239|||||||||||||||||||||||||||||||56.6|56.6|1605.5067|374418.6|
new_0222_0346|TPTX|201912|201912|201912|414.947|409.151||7.182||17.851|14.032|3.819||404.351|-122.884||||-34.1374||||5.5327|||0||6.2878||2.15|0.004|||||||35.9628|95|-0.58|35.9151||35.9151|||-0.58|0.681|||-72.131|||||5.924|-20.959|-20.959||61.91|61.91|1795.8675|633740.5|
new_0222_0346|TPTX|202001|201912|201912|||||||||||||||-29.6479||||5.1721|||0||6.8701|||||||||||||||||||||||||||||||60.45|60.45|1761.9168|603843.5|
new_0222_0346|TPTX|202002|201912|201912|||||||||||||||-24.0275||||4.4713|||0||6.3997|||||||||||||||||||||||||||||||51.15|51.15|1427.9064|366447.8|
new_0222_0346|TPTX|202003|202003|202003|389.396|380.782||6.88||14.642|11.155|3.487||381.707|-183.602||||-21.1979||||4.2029|||0||8.4364||1.846|0.004|||||||35.9194|102|-1.69|35.9222||35.9222|||-1.69||||-119.302|||||39.857|-60.718|-60.718||46.46|46.46|1259.748|363767.8|
new_0222_0346|TPTX|202004|202003|202003|||||||||||||||-18.9576||||5.0155|||0||8.7134|||||||1.2415||||||35.9252||||||||||||||||||51.51|51.51|1469.7251|290913.1667|48.0172
new_0222_0346|TPTX|202005|202003|202003|||||||||||||||-31.6538||||6.9111|||0||6.6289||||||10|1.4648||||||42.1543||||||||||||||||||68.57|68.57|2454.0252|472554|72.8226
new_0222_0346|TPTX|202006|202006|202006|718.876|710.43||6.475||14.597|11.449|3.148||710.827|-215.095||||-31.5514||||3.8317|||0||6.7794||1.33|0.005|||10|1.419|||38.6032|109|-0.82|42.1689||42.1689|||-0.82|-351.611|||-133.653|||||8.578|-31.493|-31.493||67.06|67.06|2446.0854|509579.6667|58.6978
new_0222_0346|TPTX|202007|202006|202006|||||||||||||||-22.3673||||3.5849|||0||7.3206||||||9|1.2158||||||||||||||||||||||||61.39|61.39|1878.3188|277167.5|48.6697
new_0222_0346|TPTX|202008|202006|202006|||||||||||||||-28.8702||||4.7121|||0||7.5082||||||9|1.6704||||||42.1689||||||||||||||||||74.34|74.34|2424.406|283772.1333|43.3706
new_0222_0346|TPTX|202009|202009|202009|718.163|711.388||6.202||23.045|20.256|2.789||701.588|-232.8||||-33.48|4.1074|||5.2531||0|0||8.9014||4.552|0.005|||8|1.5427|||42.1858|130|-0.42|42.2134||42.2134||35.1199|-0.42|0|||-130.875|||25||11.326|-17.705|-17.705||83.52|83.52|2811.5165|391565.8333|132.3404
new_0222_0346|TPTX|202010|202009|202009|||||||||||||||-63.0181||||6.0217|||0||5.8547||||||10|1.5403||||||47.4562||||||||||||||||||101.28|101.28|4094.9759|576115.8|141.3983
new_0222_0346|TPTX|202011|202009|202009|||||||||||||||-69.1161||||7.1807|||0||5.527||||||10|1.294||||||48.1724||||||||||||||||||108|108|4491.2312|466712.9|89.4344
new_0222_0346|TPTX|202012|202012|202012|1130.679|1122.508||5.961||26.815|24.392|2.423||1109.898|-280.176||||-82.8381|4.2306|||8.6864||0|0||4.5139||5.225|0.005|||9|1.3062|||46.6308|142|-1.02|48.6785||48.6785||46.0195|-1.02|-433.858|||-157.292|||||13.664|-47.376|-47.376||126.51|126.51|5382.9023|324529.8667|95.6173
new_0222_0346|TPTX|202101|202012|202012|||||||||||||||-60.8129||||5.617|||0||4.0438||||||9|1.2796||||||||||||||||||||||||128.07|128.07|5111.7475|292185.6667|112.1197
new_0222_0346|TPTX|202102|202012|202012|||||||||||||||-54.9848||||5.1756|||0||4.3128||||||9|1.0571||||||48.9799||||||||||||||||||117.28|117.28|4621.8547|257334.2667|128.5078
new_0222_0346|TPTX|202103|202103|202103|1121.912|1114.777||5.565||26.419|24.371|2.048||1101.165|-315.68||||-38.9049|3.1317|||3.9578||0|0||4.8679||6.784|0.005|||8|0.8511|||48.9204|169|-0.73|49.117||49.117||45.7419|-0.73||||-132.078|||25.205||19.991|-35.504|-35.504||89.5|89.5|3270.2326|355928.6|111.8003
new_0222_0346|TPTX|202104|202103|202103|||||||||||||||-38.1735||||3.4932|||0||5.5518||||||7|0.5431||||||49.1546||||||||||||||||||78.26|78.26|2731.7724|484923.8|47.9907
new_0222_0346|TPTX|202105|202103|202103|||||||||||||||-31.7209||||3.0738|||0||5.6463|||||||0.4632||||||||||||||||||||||||68.86|68.86|2270.0088|474266.3667|-3.4855
new_0222_0346|TPTX|202106|202106|202106|1091.42|1077.806||9.479||35.413|31.895|3.518||1067.507|-371.953|||-17.6958|-36.5359|2.5167|||3.3867||0|0|-11.2587|6.4757||7.088|0.005|-15.764||2|0.3713|-16.7191||49.2044||-1.14|49.3917||49.3917|0|33.7923|-1.14|0||-16.7191|-156.858|||5.164||17.171|-56.273|-56.273||75.87|75.87|2614.5825|575869.8667|20.7927
new_0222_0346|TPTX|202107|202106|202106|||||||||||||||-21.2355||||2.8224|||0||5.392||||||4|0.5955||||||||||||||||||||||||61|61|1935.0877|558798.1667|3.9583
new_0222_0346|TPTX|202108|202106|202106|||||||||||||||-29.9325||||3.5648|||0||5.1355||||||4|-0.1216||||||49.408||||||||||||||||||77.02|77.02|2727.5982|317970.0333|-1.4838
new_0222_0346|TPTX|202109|202109|202109|1047.141|1036.014||9.823||41.648|38.753|2.895||1017.337|-438.278|||-10.9496|-26.1208|2.1246|||3.2394||0|0|-13.2036|4.5797||3.188|0.005|-20.5581||4|0.8284|-20.5581||49.4265|237|-1.34|49.4642||49.4642|0|26.7338|-1.34|0||-20.5581|-205.478|||0.46||18.224|-66.325|-66.325||69.99|69.99|2380.2599|282599.4667|-23.9583
new_0222_0346|TPTX|202110|202109|202109|||||||||||||||-7.5487||||2.0246|||0||5.6402||||||2|0.2578||||||||||||||||||||||||41.64|41.64|1023.6753|576449.6333|-58.9455
new_0222_0346|TPTX|202111|202109|202109|||||||||||||||-6.2471||||1.8511|||0||4.4072||||||1|-1.1397||||||49.4795||||||||||||||||||38.06|38.06|847.1758|384243.3|-64.2629
new_0222_0346|TPTX|202112|202112|202112|992.462|981.582||8.98||49.038|47.089|1.949||954.425|-516.727|||-6.7331|-10.0965|1.3064|||2.3642|||0||4.4581||5.656|0.005|||1|-0.7678|||49.5011|250|-1.58|49.5826||49.5826|||-1.58|0|||-236.551|||||20.464|-78.449|-78.449||48.61|48.61|1369.1845|537903.5|-60.8535
new_0222_0346|TPTX|202201|202112|202112|||||||||||||||-5.7994||||1.9783|||0||4.0229||||||2|0.3383||||||||||||||||||||||||38.08|38.08|906.5234|529744.8333|-70.3323
new_0222_0346|TPTX|202202|202112|202112|||||||||||||||-4.1108||||1.7017|||0||6.0283||||||2|0.4628||||||49.6227||||||||||||||||||32.73|32.73|642.569|469458.5|-73.149
new_0222_0346|TPTX|202203|202203|202203|||||||||||||||-3.3267||||1.5733|||0|||||||||||||||||||||||||||||||||30.26|30.26|520.0009|557712.0333|-70.5384